Sign in
8-K

Current Report

Denali Therapeutics Inc. Filed Acc 0001714899-21-000007

Executive or director change · Regulation FD disclosure

  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading dnli-20210108.htm…